Akari Therapeutics plc (AKTX) insider trading

Every open-market stock purchase and sale by Akari Therapeutics plc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $2.9M over the last 12 months (8 buys).
  • Last insider buy: Hoyoung Huh (10% owner), $1.2M, 10 months ago.

Last 12 months: insiders bought $2.9M (8 buys) and sold $0 (0 sales). Last close $15.00 on Jun 9, 2026.

Recent AKTX insider trades

DateInsiderTradeValue
Jun 24, 2026Kameel D. Farag (CFO)Bought (not open market)$27.5K
Jun 24, 2026Kameel D. Farag (CFO)Bought (not open market)$13K
Jun 24, 2026Kameel D. Farag (CFO)Bought (not open market)$13K
Jun 24, 2026Kameel D. Farag (CFO)Bought (not open market)$13K
Jun 24, 2026Kameel D. Farag (CFO)Bought (not open market)$13K
Jun 24, 2026Kameel D. Farag (CFO)Bought (not open market)$13K
Jun 24, 2026Kameel D. Farag (CFO)Bought (not open market)$12.5K
Jun 24, 2026Abizer Gaslightwala (CEO)Bought (not open market)—
Jun 24, 2026Abizer Gaslightwala (CEO)Bought (not open market)—
Dec 16, 2025Hoyoung Huh (10% owner)Bought$1.2M
Dec 16, 2025Abizer Gaslightwala (CEO)Bought$312K
Dec 16, 2025Samir Rashmikant Patel (10% owner)Bought$250K
Dec 16, 2025Raymond Prudo-Chlebosz (Director)Bought$250K
Dec 16, 2025Hoyoung Huh (10% owner)Bought$250K
Dec 16, 2025Raymond Prudo-Chlebosz (Director)Bought$156K
Dec 16, 2025Abizer Gaslightwala (CEO)Bought$125K
Dec 16, 2025Sandip I Patel (Director)Bought$100K
Dec 16, 2025Samir Rashmikant Patel (10% owner)Bought$93.7K
Dec 16, 2025Sandip I Patel (Director)Bought$62.5K
Dec 16, 2025Robert B Bazemore (Director)Bought$50K
Dec 16, 2025Robert B Bazemore (Director)Bought$12.5K
Dec 16, 2025Kameel D. Farag (CFO)Bought$10K
Dec 16, 2025James R Neal (Director)Bought$1.2K
Dec 16, 2025James R Neal (Director)Bought$999
Nov 1, 2025Kameel D. Farag (CFO)Bought (not open market)$24K

Who's trading AKTX

Get free alerts when an insider at Akari Therapeutics plc files a new trade →